{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:58:01Z","timestamp":1773287881351,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.intimp.2006.08.010","type":"journal-article","created":{"date-parts":[[2006,9,9]],"date-time":"2006-09-09T11:17:32Z","timestamp":1157800652000},"page":"46-54","source":"Crossref","is-referenced-by-count":20,"title":["Immunotherapy with CpG DNA conjugated with T-cell epitope peptide of an allergenic Cry j 2 protein is useful for control of allergic conditions in mice"],"prefix":"10.1016","volume":"7","author":[{"given":"Motohiko","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ping","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamami","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xusheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Toida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2006.08.010_bib1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1164\/ajrccm.153.1.8542101","article-title":"Pretreatment with allergen prevents immediate hypersensitivity and airway hyperresponsiveness","volume":"153","author":"Oshiba","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2006.08.010_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-6749(98)70294-5","article-title":"Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats","volume":"102","author":"Pene","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib3","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1084\/jem.178.5.1783","article-title":"Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice","volume":"178","author":"Hoyne","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2006.08.010_bib4","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1038\/nm1226","article-title":"Peptide-based therapeutic vaccines for allergic and autoimmune diseases","volume":"11","author":"Larche","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.intimp.2006.08.010_bib5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jaci.2004.03.020","article-title":"Immunotherapy: 1999\u20132004","volume":"113","author":"Norman","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0091-6749(98)70334-3","article-title":"Oral administration of a dominant T cell determinant peptide inhibits allergen-specific Th1 and Th1 responses in Cry j 2-primed mice","volume":"192","author":"Hirahara","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mai.2002.126660","article-title":"Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity","volume":"110","author":"Horner","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1067\/mai.2000.107927","article-title":"Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity","volume":"106","author":"Tighe","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib9","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0091-6749(99)70018-7","article-title":"Immunostimulatory. oligodeoxynucleotide induces TH1 immune response and inhibition of IgE antibody production to cedar pollen allergen in mice","volume":"104","author":"Kohama","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib10","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.4049\/jimmunol.162.10.6284","article-title":"Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides","volume":"162","author":"Sur","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaci.2003.11.001","article-title":"Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response","volume":"113","author":"Tulic","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0897-849","article-title":"Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants","volume":"3","author":"Roman","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.intimp.2006.08.010_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1081-1206(10)61163-5","article-title":"DNA-based immunotherapy to treat atopic disease","volume":"95","author":"Tsalik","year":"2005","journal-title":"Ann Allergy, Asthma, & Immun"},{"key":"10.1016\/j.intimp.2006.08.010_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1398-9995.1995.tb02479.x","article-title":"1995 causative allergens of allergic rhinitis in Japan with special reference to silkworm moth allergen","volume":"50","author":"Suzuki","year":"1995","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2006.08.010_bib15","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-2222.1995.tb00027.x","article-title":"Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis","volume":"25","author":"Hashimoto","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.intimp.2006.08.010_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2567.2002.01534.x","article-title":"Three T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen antigens, retain their immunogenicity and tolerogenicity in a linked peptide","volume":"107","author":"Yoshitomi","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2006.08.010_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.1990.tb00501.x","article-title":"Identification of the second major allergen of Japanese cedar pollen","volume":"45","author":"Sakaguchi","year":"1990","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2006.08.010_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0014-2999(02)02005-8","article-title":"Participation of chemical mediators other than histamine in nasal allergy signs: a study using mice lacking histamine H(1) receptors","volume":"449","author":"Kayasuga","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.intimp.2006.08.010_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2006.08.010_bib20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0960-9822(00)00700-4","article-title":"Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88","volume":"10","author":"Schnare","year":"2000","journal-title":"Curr Biol"},{"key":"10.1016\/j.intimp.2006.08.010_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1084\/jem.192.4.595","article-title":"Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6","volume":"192","author":"Hacker","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2006.08.010_bib22","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.164.2.944","article-title":"Mechanism and function of a newly identified CpG DNA motif in human primary B cells","volume":"164","author":"Hartmann","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4049\/jimmunol.161.1.448","article-title":"T cell epitope in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis","volume":"161","author":"Sone","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib24","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8","article-title":"Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells","volume":"28","author":"Sparwasser","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.168.1.5","article-title":"Cutting Edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3'-OH kinase pathway","volume":"168","author":"Park","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib26","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/1521-4141(200208)32:8<2356::AID-IMMU2356>3.0.CO;2-Z","article-title":"CpG-DNA aided cross-presentation of soluble antigens by dendritic cells","volume":"32","author":"Maurer","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4049\/jimmunol.167.1.66","article-title":"Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells","volume":"167","author":"Shirota","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2006.08.010_bib28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1172\/JCI119255","article-title":"Systemic anaphylaxis in mouse can be mediated through IgG1 and Fc gamma RIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE-or IgG-dependent passive anaphylaxis","volume":"99","author":"Miyajima","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2006.08.010_bib29","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/80525","article-title":"Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group","volume":"6","author":"Kappos","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.intimp.2006.08.010_bib30","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1172\/JCI0215488","article-title":"Anti-peptide autoantibodies and fetal anaphylaxis in NOD mice response to insulin self-peptides B:9-23 and B:13-23","volume":"110","author":"Liu","year":"2002","journal-title":"J Clin Invest"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576906002554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576906002554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T20:12:54Z","timestamp":1683576774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576906002554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1567576906002554"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2006.08.010","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}